Brief: Mesoblast Ltd Says Mesoblast Resubmits BLA With FDA For Ryoncil Approval
09/07/2024 02:26
July 9 (Reuters) - Mesoblast Ltd MSB.AX :
* MESOBLAST RESUBMITS BLA WITH FDA FOR RYONCIL APPROVAL
Further company coverage: MSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast William Burns To Retire From Board At 2026 AGM
Brief: Mesoblast Says Q1 Net Revenues Up 44%
Australia's Mesoblast hits one-month high on upbeat quarterly update
Australia's Mesoblast drops as Bell Potter cuts target price after key drug misses sales view
Brief: Mesoblast Says FDA Approves New Potency Assay For Commercial Ryoncil